Page last updated: 2024-11-13
laspartomycin c
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
laspartomycin C: an acidic lipopeptide antibiotic with a unique peptide core; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 71718509 |
CHEMBL ID | 2304223 |
MeSH ID | M0509262 |
Synonyms (2)
Synonym |
---|
laspartomycin c |
CHEMBL2304223 |
Research Excerpts
Overview
Laspartomycin C is a lipopeptide antibiotic with activity against a range of Gram-positive bacteria including drug-resistant pathogens.
Excerpt | Reference | Relevance |
---|---|---|
"Laspartomycin C is a lipopeptide antibiotic with activity against a range of Gram-positive bacteria including drug-resistant pathogens. " | ( Total Synthesis of Laspartomycin C and Characterization of Its Antibacterial Mechanism of Action. 't Hart, P; Breukink, E; Kemmink, J; Kleijn, LH; Martin, NI; Martin-Visscher, LA; Oppedijk, SF; van Harten, RM, 2016) | 2.21 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (1)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID280571 | Antimicrobial activity against methicillin-sensitive Staphylococcus aureus Smith ATCC 19636 by tube dilution method | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Semisynthetic approaches to laspartomycin analogues. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.79
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.79) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |